Cargando…
Fatty acid amides as potential circulating biomarkers for sarcopenia
BACKGROUND: Sarcopenia is characterized by a progressive decrease in skeletal muscle mass and function with age. Given that sarcopenia is associated with various metabolic disorders, effective metabolic biomarkers for its early detection are required. We aimed to investigate the metabolic biomarkers...
Autores principales: | Kim, Ye An, Lee, Seung Hun, Koh, Jung‐Min, Kwon, Seung‐hyun, Lee, Young, Cho, Han Jin, Kim, Hanjun, Kim, Su Jung, Lee, Ji Hyun, Yoo, Hyun Ju, Seo, Je Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235865/ https://www.ncbi.nlm.nih.gov/pubmed/37127296 http://dx.doi.org/10.1002/jcsm.13244 |
Ejemplares similares
-
Vitreous Fatty Amides and Acyl Carnitines Are Altered in Intermediate Age-Related Macular Degeneration
por: Yoon, Chang-Ki, et al.
Publicado: (2023) -
Unveiling genetic variants for age-related sarcopenia by conducting a genome-wide association study on Korean cohorts
por: Jin, Heejin, et al.
Publicado: (2022) -
Lower Serum n-3 Fatty Acid Level in Older Adults with Sarcopenia
por: Jang, Il-Young, et al.
Publicado: (2020) -
Prediction of sarcopenia using a combination of multiple serum biomarkers
por: Kwak, Ju Yeon, et al.
Publicado: (2018) -
Synthesis, Characterization, and Retinol Stabilization of Fatty Amide-β-cyclodextrin Conjugates
por: Kim, Hwanhee, et al.
Publicado: (2016)